Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Wall Street is suffering from volatility in the first quarter of 2025. Out of the three large-cap indexes, the S&P 500 and ...

With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...

Esteve Química, the CDMO division of leading specialty pharmaceutical company ESTEVE, has been named the Champion of the 2025 CDMO Leadership Award in the Small Molecule API – Global Category. This ...

Milestone Pharmaceuticals faces a pivotal FDA PDUFA decision for etripamil in PSVT. Read here for a detailed investment ...

Novartis was announced as an official partner of this year’s Eurovision competition last fall, after the song entry from ...

Highlighting deals by PE firms pursuing investments in marketing agencies focused on pharma and life sciences; insights on a ...

PE Hub rounded up five pharma marketing deals from the last five months, starting with the most recently announced. (We have ...

German drugmaker Grünenthal pushed its latest opioid as a safer option. People around the world got hooked. Madlen Davies, Hristio Boytchev, and Rafael Cabrera report.

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non ...